For the Inventor, By the Inventor

Enter inventor name

San Francisco, CA, United States of America

Kenneth Victor Lawson

USPTO Granted Patents = 19 (Patent Applications = 4)

EPO Patents = 2 (Patent Applications = 10)

Average Co-Inventor Count = 6.4

ph-index = 4

Forward Citations = 63(Granted Patents)

Location History:

Riverside, CA (US) (2001)
San Francisco, CA (US) (2019 - 2024)

Company Filing History:

Arcus Biosciences, Inc.

1 out of 832,880

Other

patents

Years Active: 2001-2025

Loading Chart...

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12459967 - Modulators of 5'-nucleotidase, ecto and the use thereof (2025-11-04),

2. 12433836 - Parenterally administered immune enhancing drugs (2025-10-07),

3. 12410170 - 2,3,5-trisubstituted pyrazolo[1,5-A]pyrimidine compounds (2025-09-09),

4. 12168023 - Inhibitors of adenosine 5'-nucleotidase (2024-12-17),

5. 12145901 - Process for preparing tetralin compounds (2024-11-19),

6. 12103907 - Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha (2024-10-01),

7. 12071411 - Inhibitors of HIF-2α and methods of use thereof (2024-08-27),

8. 11931343 - CD73 inhibitors (2024-03-19),

9. 11819512 - Solid forms of a CD73 inhibitor and the use thereof (2023-11-21),

10. 11787762 - Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha (2023-10-17),

11. 11667662 - Modulators of 5'-nucleotidase, ecto and the use thereof (2023-06-06),

12. 11633416 - Oral formulations of CD73 compounds (2023-04-25),

13. 11407712 - Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α (2022-08-09),

14. 11267845 - Inhibitors of CD73-mediated immunosuppression (2022-03-08),

15. 11058704 - Inhibitors of adenosine 5'-nucleotidase (2021-07-13),

Title: Kenneth Victor Lawson: Innovator in Immune Enhancing Drugs

Introduction

Kenneth Victor Lawson is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of immune enhancing drugs. With a total of 18 patents to his name, Lawson's work has the potential to impact the treatment of various diseases and disorders.

Latest Patents

Among his latest patents, Lawson has developed methods for identifying compounds that modulate the conversion of AMP to adenosine by 5'-nucleotidase, ecto. These compounds possess specific pharmacokinetic characteristics and are aimed at treating a diverse array of diseases, including cancer and immune-related disorders. Another notable patent involves 2,3,5-trisubstituted pyrazolo[1,5-A]pyrimidine compounds, which inhibit PI3Kγ. The methods for synthesizing these compounds and their applications in treating diseases mediated by PI3Kγ are also described.

Career Highlights

Lawson has worked with various companies, including Arcus Biosciences, Inc. His career reflects a commitment to advancing medical science through innovative drug development. His extensive research and patent portfolio underscore his expertise in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Manmohan Reddy Leleti and Jay Patrick Powers. Their collaborative efforts have contributed to the success of Lawson's projects and innovations.

Conclusion

Kenneth Victor Lawson is a distinguished inventor whose work in immune enhancing drugs has the potential to transform treatment options for numerous health conditions. His contributions to the field are invaluable and continue to inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…